Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
Yanjie You,1,* Yuhong Ma,1,* Qiang Wang,2,* Zhengcai Ye,3 Yanhong Deng,1 Feihu Bai1 1Department of Gastroenterology, Ningxia Hui Autonomous Region People’s Hospital, Yinchuan 750021, China; 2Department of Science and Education, Ningxia Hui Autonomous Region People’s Hospital, Yin...
Main Authors: | You Y, Ma Y, Wang Q, Ye Z, Deng Y, Bai F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/attenuated-zhx3-expression-serves-as-a-potential-biomarker-that-predic-peer-reviewed-article-CMAR |
Similar Items
-
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
by: Zhai Cai, et al.
Published: (2024-01-01) -
Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
by: Natália Ioseph Gladistone Maciel, et al.
Published: (2021-02-01) -
Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
by: Anqi Cheng, et al.
Published: (2021-06-01) -
ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
by: Wentong Fang, et al.
Published: (2021-11-01) -
ZHX2 in health and disease
by: Na Li, et al.
Published: (2022-11-01)